The Groundbreaking Biobeat Monitoring Platform Provides an Ideal Solution in Caring for Coronavirus Patients

News provided by

Mar 11, 2020, 09:00 ET

TEL AVIV, Israel, March 11, 2020 /PRNewswire/ -- Israeli hospitals all over the country are now prepared with designated isolation units for Coronavirus patients. Biobeat, an Israeli company that developed a novel medical grade sensor for continuous monitoring of vital signs, has already installed their monitoring platform in 11 hospitals across the country, and will continue installing in several more over the coming week. Biobeat is also working closely with several authorities in the country to implement monitoring of home hospitalized patients, being the first company to provide a comprehensive and advanced tracking solution of their medical condition and deterioration as needed from afar.

Biobeat single-use medical monitoring patch for COVID-19 patients

The Biobeat platform allows continuous monitoring using a wireless, medical grade, non-invasive optical sensor. It measures 16 different vital signs including cuffless blood pressure, heart rate, blood oxygen saturation, respiratory rate, stroke volume, cardiac output, systemic vascular resistance and temperature – all in one small wearable device. The data is automatically transmitted in real time to the cloud and can be accessed from anywhere by the medical staff, providing relevant alerts when a change is detected. This dramatically reduces the direct contact between patients and health care providers, decreasing the risk for secondary exposure of the medical teams.

"This is the first time we can closely monitor individuals while keeping our healthcare providers safe without compromising the medical support they provide," shared Prof. Arik Eisenkraft, Biobeat's Chief Medical Officer. "We intend to use the valuable data gathered from monitored subjects to analyze the influence of the virus on humans and the effectiveness of the medical treatments given."

Biobeat is at the forefront of the medical response and efforts in combating this global pandemic. Their team is excited to see that this groundbreaking technology, used for routine monitoring of hospitalized and home-based patients, has a high impact on the way this situation is managed.

Website: www.bio-beat.com

Contact: Romi Littman, Business Development Manager: [email protected]

SOURCE Biobeat